Author: Kyle LaHucik
June 6, 2023

To intro last year’s inaugural Endpoints News feature on LGBTQ+ leaders in biopharma, I wrote about the movement and progress being made for this community.

I feel I might have jinxed it in some ways. Anti-LGBTQ+ bills are running rampant through the US, children can no longer read gay books in some regions and this community still feels misunderstood by the pharma world.

Being LGBTQ+ is just one part of a person’s identity, but a critical one that often is not visible to outsiders, as some people on this year’s list point out. Others worry the recent onslaught of anti-gay rhetoric in some corners will force LGBTQ+ people to no longer feel comfortable speaking out or being open about who they are in the workplace.

Read full story here.